Composition:
Each film coated contains Entecavir (as monohydrate) 1 mg

Indication:
Chronic hepatitis B in patients with compensated liver disease (with
evidence of viral replication, and histologically documented active liver
inflammation or fibrosis) not previously treated with nucleoside analogues
Chronic hepatitis B in patients with compensated liver disease
(with evidence of viral replication, and histologically documented
active liver inflammation or fibrosis) and lamivudine-resistance
Chronic hepatitis B in patients with decompensated liver disease